Skip to main content

Table 3 Rates of NR*, ETR† and SVR‡ in HCV infected patients of different Age groups to interferon plus ribavirin therapy (N = 400).

From: A study of best positive predictors for sustained virologic response to interferon alpha plus ribavirin therapy in naive chronic hepatitis C patients

S. No.

AGE GROUP

TOTAL PATIENTS

NR (%)

ETR (%)

SVR (%)

1

≤ 20 Years

9

1 (11.1%)

8 (88.9%)

6 (66.7%)

2

21–30 Years

91

27 (29.7%)

64 (70.3%)

50 (54.9%)

3

31–40 Years

154

48 (31.2%)

106 (68.8%)

88 (57.1%)

4

41–50 Years

107

40 (37.4%)

67 (62.6%)

48 (44.9%)

5

51–60 Years

37

14 (37.8%)

23 (62.2%)

10 (27.1%)

6

> 60 Years

2

2 (100%)

0

0

Total

 

400

132 (33%)

268 (67%)

202 (50.5%)

  1. *NR, Non-responders, defined as detectable HCV RNA at the end of anti-viral treatment.
  2. †ETR, End of treatment response, defined as undetectable HCV RNA at the end of treatment.
  3. ‡SVR-Sustained virologic response, defined as undetectable HCV RNA 24 weeks after end of anti-viral treatment.
Back to article page